Table 5.

Discharge prescription rates of antiplatelet agents/anticoagulants, β-blockers, LLDs, and blockers of the renin-angiotensin system according to estimated CrC

Medication Use≤45 ml/min (n = 144)45 to 60 ml/min (n = 192)>60 ml/min (n = 722)Differencea
Aspirin (%)123 (85)175 (91)678 (94)−9 (−15, −3)b
Any antiplatelet agent (%)130 (90)179 (93)705 (98)−8 (−13, −3)b
Warfarin (%)28 (19)23 (12)57 (8)11 (4, 18)b
Any antiplatelet agent/warfarin (%)143 (99)189 (98)719 (100)−1 (−3, 1)
β-blockers (%)107 (74)160 (83)599 (83)−9 (−17, −1)b
LLDs (%)105 (73)140 (73)579 (80)−7 (−13, −1)b
ACE inhibitor/ARB (%)94 (65)122 (63)421 (58)7 (−1, 15)
  • a Reported differences are between subjects with a CrC ≤45 ml/min and the reference group (>60 ml/min) and are expressed in % with a 95% CI.

  • b P ≤ 0.05 by χ2 for a difference between the three groups.